α-Synuclein aggregation nucleates through liquid–liquid phase separation | Nature Chemistry
Zeroing in on neurodegenerative α-synuclein | Nature Reviews Drug Discovery
Biomolecules | Free Full-Text | Seeking a Mechanism for the Toxicity of Oligomeric α-Synuclein | HTML
CMT-3 targets different α-synuclein aggregates mitigating their toxic and inflammogenic effects | Scientific Reports
Detection of α -synuclein oligomers in synucleinopathy brains using... | Download Scientific Diagram
Classification of α-synuclein-induced changes in the AAV α-synuclein rat model of Parkinson's disease using electrophysiological measurements of visual processing | Scientific Reports
α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies | Nature Medicine
PDF) The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease
Molecules | Free Full-Text | Anti-aggregation Effects of Phenolic Compounds on α-synuclein | HTML
Chronic nigral neuromodulation aggravates behavioral deficits and synaptic changes in an α-synuclein based rat model for Parkinson's disease | Acta Neuropathologica Communications | Full Text
Spread of α-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis | Nature Neuroscience
Transmission of α-synuclein seeds in neurodegenerative disease: recent developments | Laboratory Investigation
The interplay between Glucocerebrosidase, α-synuclein and lipids in human models of Parkinson's disease - ScienceDirect
Alleviating toxic α-Synuclein accumulation by membrane depolarization: evidence from an in vitro model of Parkinson's disease | Molecular Brain | Full Text
Structure, function and toxicity of alpha‐synuclein: the Bermuda triangle in synucleinopathies - Villar‐Piqué - 2016 - Journal of Neurochemistry - Wiley Online Library
Elevated α -synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells | Cell Death & Disease
Frontiers | Modeling Parkinson's Disease With the Alpha-Synuclein Protein | Pharmacology
Ca2+ is a key factor in α-synuclein-induced neurotoxicity
Frontiers | New Perspectives on Roles of Alpha-Synuclein in Parkinson's Disease | Frontiers in Aging Neuroscience
Animal models of α-synucleinopathy for Parkinson disease drug development | Nature Reviews Neuroscience
Classification of α-synuclein-induced changes in the AAV α-synuclein rat model of Parkinson's disease using electrophysiological measurements of visual processing | Scientific Reports
A Pathologic Cascade Leading to Synaptic Dysfunction in α-Synuclein-Induced Neurodegeneration | Journal of Neuroscience
PDF) Classification of α-synuclein-induced changes in the AAV α-synuclein rat model of Parkinson's disease using electrophysiological measurements of visual processing
Expression of α-synuclein is regulated in a neuronal cell type-dependent manner | SpringerLink
